AUSTRALIAN Prescriber is celebrating its 50 year anniversary this year, thanking its 100,000 plus healthcare subscribers for their continued support over the years.
The publication is a free, national, peer-reviewed journal providing critical commentary on drugs and therapeutics, providing independent, reliable and accessible information on the quality use of medicines to support clinical decision-making and improve patient outcomes.
"While there has been much growth and change during this time, our purpose - to help health professionals make informed choices when prescribing - remains the same," wrote Managing Editor Rosie Scott in an editorial commemorating the anniversary.
First published by the Department of Health and then NPS MedicineWise, Australian Prescriber has been published by Therapeutic Guidelines Ltd since 2023, and is funded by the Australian Government Department of Health and Aged Care.
The move to Therapeutic Guidelines Ltd, which also publishes the Therapeutic Guidelines, a point-of-care clinical decision support database, provided opportunity for continued growth and quality, with collaboration across publications and with subject matter experts.
"Recognising the custodial responsibility, Therapeutic Guidelines Limited is committed to continue to evolve, rejuvenate and grow the publication for the benefit of all healthcare professionals," wrote Scott.
The journal was recently indexed by the International OA Journal Recommended List, a list of open access journals that meet international standards for academic integrity and quality.
"It is wonderful to see the positive impact of the continuous work that is done to achieve our purpose of helping health professionals make informed decisions when prescribing," wrote Scott. KB
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Feb 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Feb 25
